Shots: The two companies will co-develop and conduct clinical trials for senaparib across multiple cancer indications in China. Junshi to invest $43.4M in cash, representing 50% of the JV while […]readmore
Tags : Establish
Shots: Sanofi to create a standalone company which will combine its API commercial and development activities with six of its API’s production sites in Italy, Germany, UK, France and Hungary […]readmore
Shots: The companies partnered to form JV focusing on the marketing, market access, and medical affairs activities for the IV iron portfolio. Vifor Pharma will own 55% while the Fresenius […]readmore
Shots: Bayer to transfer its small molecule research unit to Nuvisan for establishing a new research center in Berlin. The transaction is expected to close mid of 2020 The collaboration […]readmore
Shots: The approval will increase the production capacity of Ruconest and allows Pharming to release the therapy manufactured at the facility during the approval process for commercialization in the EU […]readmore
Shots: Astellas will construct the Third Fermentation Building as the manufacturing facility for API of Prograf (tacrolimus hydrate) in the Toyama Technology Center of Astellas Pharma The establishment of the […]readmore
Shots: JWP to acquire all stock of Chugai in C&C by 31 Dec 2019. C&C will be a wholly-owned subsidiary of JWP and will continue its R&D with independent management. […]readmore